Dr. Thomas Lehmann
Leitender Arzt
Leitung Fachbereich Hämatologie
Medizinische Onkologie und Hämatologie · Dept. I
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
Emanuel R, Dueck A, Geyer H, Kiladjian J, Slot S, Zweegman S, te Boekhorst P, Commandeur S, Schouten H, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl H, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto J, Ranta D, Roy L, Cahn J, Harrison C, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson P, Barbui T, Barosi G, Vannucchi A, Passamonti F, Andreasson B, Ferrari M, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa R. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol 2012; 30:4098-103.
15.10.2012Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
15.10.2012J Clin Oncol 2012; 30:4098-103
Emanuel Robyn M, Dueck Amylou C, Geyer Holly L, Kiladjian Jean-Jacques, Slot Stefanie, Zweegman Sonja, te Boekhorst Peter A W, Commandeur Suzan, Schouten Harry, Sackmann Federico, Kerguelen Fuentes Ana, Hernández-Maraver Dolores, Pahl Heike L, Griesshammer Martin, Stegelmann Frank, Doehner Konstanze, Lehmann Thomas, Bonatz Karin, Reiter Andreas, Boyer Francoise, Etienne Gabriel, Ianotto Jean-Christophe, Ranta Dana, Roy Lydia, Cahn Jean-Yves, Harrison Claire N, Radia Deepti, Muxi Pablo, Maldonado Norman, Besses Carlos, Cervantes Francisco, Johansson Peter L, Barbui Tiziano, Barosi Giovanni, Vannucchi Alessandro M, Passamonti Francesco, Andreasson Bjorn, Ferrari Maria L, Rambaldi Alessandro, Samuelsson Jan, Birgegard Gunnar, Tefferi Ayalew, Mesa Ruben A
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
Girsberger S, Karow A, Lundberg P, Dirnhofer S, Lehmann T, Passweg J, Tichelli A, Skoda R, Rovó A. JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report. Acta Haematol 2012; 129:23-5.
19.09.2012JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
19.09.2012Acta Haematol 2012; 129:23-5
Girsberger Sabine, Karow Axel, Lundberg Pontus, Dirnhofer Stephan, Lehmann Thomas, Passweg Jakob R, Tichelli André, Skoda Radek C, Rovó Alicia
A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency.
Medinger M, Saller E, Harteveld C, Lehmann T, Graf L, Rovó A, Buser A, Passweg J, Tichelli A. A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency. Hematol Rep 2011; 3:e30.
06.12.2011A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency.
06.12.2011Hematol Rep 2011; 3:e30
Medinger Michael, Saller Elisabeth, Harteveld Cornelis L, Lehmann Thomas, Graf Lukas, Rovó Alicia, Buser Andreas, Passweg Jakob, Tichelli André
Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2.
Schaub F, Lehmann T, Looser R, Hao-Shen H, Tichelli A, Skoda R. Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2. Blood 2011; 117:2075-6.
10.02.2011Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2.
10.02.2011Blood 2011; 117:2075-6
Schaub Franz X, Lehmann Thomas, Looser Renate, Hao-Shen Hui, Tichelli André, Skoda Radek C
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
Passamonti F, Elena C, Schnittger S, Skoda R, Green A, Girodon F, Kiladjian J, McMullin M, Ruggeri M, Besses C, Vannucchi A, Lippert E, Gisslinger H, Rumi E, Lehmann T, Ortmann C, Pietra D, Pascutto C, Haferlach T, Cazzola M. Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood 2011; 117:2813-6.
11.01.2011Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
11.01.2011Blood 2011; 117:2813-6
Passamonti Francesco, Elena Chiara, Schnittger Susanne, Skoda Radek C, Green Anthony R, Girodon François, Kiladjian Jean-Jacques, McMullin Mary Frances, Ruggeri Marco, Besses Carles, Vannucchi Alessandro M, Lippert Eric, Gisslinger Heinz, Rumi Elisa, Lehmann Thomas, Ortmann Christina A, Pietra Daniela, Pascutto Cristiana, Haferlach Torsten, Cazzola Mario
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
Halter J, Schüpbach W, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T, Mandel H, Martinez R, Mattle H, Orchard K, Savage D, Sue C, Valcarcel D, Gratwohl A, Hirano M. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2010; 46:330-337.
03.05.2010Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
03.05.2010Bone Marrow Transplant 2010; 46:330-337
Halter J, Schüpbach Wmm, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann Thomas, Mandel H, Martinez Raquel, Mattle Heinrich P, Orchard K, Savage David B, Sue C M, Valcarcel D, Gratwohl A, Hirano M
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms.
Schaub F, Looser R, Li S, Hao-Shen H, Lehmann T, Tichelli A, Skoda R. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood 2010; 115:2003-7.
08.01.2010Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms.
08.01.2010Blood 2010; 115:2003-7
Schaub Franz X, Looser Renate, Li Sai, Hao-Shen Hui, Lehmann Thomas, Tichelli André, Skoda Radek C
Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.
Khanna N, Steffen I, Studt J, Schreiber A, Lehmann T, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch H. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009; 11:100-5.
20.01.2009Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.
20.01.2009Transpl Infect Dis 2009; 11:100-5
Khanna N, Steffen Imke, Studt J-D, Schreiber A, Lehmann Thomas, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch H H
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial.
Maggiorini M, Brunner-La Rocca H, Peth S, Fischler M, Böhm T, Bernheim A, Kiencke S, Bloch K, Dehnert C, Naeije R, Lehmann T, Bärtsch P, Mairbäurl H. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145:497-506.
03.10.2006Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial.
03.10.2006Ann Intern Med 2006; 145:497-506
Maggiorini Marco, Brunner-La Rocca Hans-Peter, Peth Simon, Fischler Manuel, Böhm Thomas, Bernheim Alain, Kiencke Stefanie, Bloch Konrad E, Dehnert Christoph, Naeije Robert, Lehmann Thomas, Bärtsch Peter, Mairbäurl Heimo
Platelet count and function at high altitude and in high-altitude pulmonary edema.
Lehmann T, Mairbäurl H, Pleisch B, Maggiorini M, Bärtsch P, Reinhart W. Platelet count and function at high altitude and in high-altitude pulmonary edema. J Appl Physiol (1985) 2006; 100:690-4.
01.02.2006Platelet count and function at high altitude and in high-altitude pulmonary edema.
01.02.2006J Appl Physiol (1985) 2006; 100:690-4
Lehmann Thomas, Mairbäurl Heimo, Pleisch B, Maggiorini M, Bärtsch P, Reinhart W H